Omnicell Market Cap 2010-2023 | OMCL

Omnicell market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Omnicell market cap as of April 24, 2024 is $1.31B.
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.306B $1.147B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.087B 0.00
IRhythm Technologies (IRTC) United States $3.621B 0.00
Axonics (AXNX) United States $3.390B 0.00
10x Genomics (TXG) United States $3.287B 0.00
Enovis (ENOV) United States $3.042B 23.11
Azenta (AZTA) United States $2.930B 238.82
Olink Holding AB (publ) (OLK) Sweden $2.760B 0.00
Hims & Hers Health (HIMS) United States $2.642B 0.00
Privia Health (PRVA) United States $2.231B 98.95
Schrodinger (SDGR) United States $1.794B 0.00
Phreesia (PHR) United States $1.305B 0.00
Definitive Healthcare (DH) United States $0.856B 0.00
Standard BioTools (LAB) United States $0.743B 0.00
Fulgent Genetics (FLGT) United States $0.617B 0.00
Talkspace (TALK) United States $0.530B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.289B 0.00
P3 Health Partners (PIII) United States $0.162B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
American Well (AMWL) United States $0.157B 0.00
Butterfly Network (BFLY) United States $0.154B 0.00
Augmedix (AUGX) United States $0.138B 0.00
Outset Medical (OM) United States $0.127B 0.00
TruBridge (TBRG) United States $0.119B 5.06
111 (YI) China $0.091B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.014B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00